Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Research Type:

Filter Results By

Filter Applied. Clear All

Latest Posts

May 13, 2024 New Study Reveals FDA Relied on Cherrypicked Data to Approve Dangerous Mail-Order Abortion Drugs New Study Reveals FDA Relied on Cherrypicked Data to Approve Dangerous Mail-Order Abortion Drugs May 9, 2024 Abortion Reporting: Oklahoma (2023) Abortion Reporting: Oklahoma (2023) April 30, 2024 Gestational Limits on Abortion in the United States Compared to International Norms (April 2024) Gestational Limits on Abortion in the United States Compared to International Norms (April 2024)
Reset All Filters
Maternal & Public Health

Abortion Reporting: Illinois (2022)

Abortions in Illinois increased in 2022 by 9% from 2021, with a total of 56,457 in 2022 and 51,797 in 2021.

Maternal & Public Health

Abortion Reporting: Wisconsin (2022)

Wisconsin’s 2022 abortion report was released in January 2024, showing that abortions decreased significantly from 2021.

Maternal & Public Health

Abortion Reporting: Oregon (2022)

A total of 8,672 abortions were reported in Oregon in 2022, an increase of 22% from 2021.

Maternal & Public Health

CLI Authors’ Responses to Sage Concerns and Retractions

On February 5, 2024, Sage Publications retracted three peer-reviewed articles authored by affiliates of the Charlotte Lozier Institute. Prior to these retractions, Sage issued an expression of concern against the first of the three articles in July of 2023. Reproduced here are the authors’ initial response to Sage’s notice informing CLI of its intention to issue an expression of concern, as well as the authors’ subsequent response to the official retractions.

Lozier Institute Amicus Brief in Support of Ecuador Law Limiting Abortion
Fetal Tissue, Stem Cells & Bioethics

Lozier Institute Amicus Brief in Support of Ecuador Law Limiting Abortion

On February 19, 2024, CLI associate scholar Mary E. Harned, J.D., submitted an amicus brief on behalf of CLI to the Constitutional Court of Ecuador. This brief was written in support of three provisions of Ecuador’s Organic Law Regulating the Voluntary Interruption of Pregnancy: (1) a requirement that ultrasounds be performed prior to abortion decisions, (2) a 12-week gestational age limit on abortion, and (3) a prohibition on the commodification of post-abortion fetal remains. Following is CLI’s amicus brief reproduced in full.

Fetal Tissue, Stem Cells & Bioethics

Public Comment: Lozier Institute on CDC’s Notice of Proposed Modifications to Assisted Reproductive Technology Program Reporting

On January 25, 2024, CLI submitted a public comment to the CDC regarding newly proposed modifications related to data collection and reporting from assisted reproductive technology programs and modifications to data validation procedures. In light of the fact that none of these proposed changes recognized the inherent value and dignity of nascent human beings created from ART programs, including IVF, CLI took the opportunity to encourage the CDC to do so and to consider limiting, reporting, or regulating "the number of living embryos destined for research and destruction."

CLI Scholars React to Nature Medicine Study
Chemical Abortion

CLI Scholars React to Nature Medicine Study

Following the release of a study in Nature Medicine, which discussed the “safety and effectiveness” of abortion drugs acquired through telehealth, Tessa Longbons Cox, senior research associate at the Charlotte Lozier Institute, made the following statement:

Maternal & Public Health

Five Facts About “Life-Limiting” Fetal Conditions

Babies prenatally diagnosed with a life-limiting condition often face discrimination. Some continue to refer to these conditions as “lethal” or “fatal” or “incompatible with life.” In such cases abortion is often offered as the only option to families. The fact is, however, that some of these babies may require very minimal medical support after birth or may benefit and be stabilized for further evaluation with medical interventions routinely performed on babies without lethal labels.

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image